Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, and bacterial vaccines; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments, quality system and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
Frequently asked questions
What sector does Labiana Health S.A. (LAB) operate in?
Labiana Health S.A. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Labiana Health S.A. (LAB) current stock price?
As of the latest data, Labiana Health S.A. stock price is €6.40, with a previous close of €6.30. Labiana Health S.A. gained €0.10 in the last trading session, representing a 1.59% increase.
What is Labiana Health S.A. (LAB) current market capitalization?
Labiana Health S.A. market cap is approximately 54.33 million.
What is Labiana Health S.A. (LAB) Earnings Per Share (EPS)?
The trailing EPS is €0.36, and the forward EPS is €0.97.
What is Labiana Health S.A. (LAB) Price-to-Earnings (P/E) ratio?
Labiana Health S.A. current P/E ratio is 17.78, with a forward P/E of 6.58.
Does Labiana Health S.A. (LAB) pay dividends?
No. Labiana Health S.A. does not pay a dividend.
What is Labiana Health S.A. (LAB) beta (volatility) score?
Labiana Health S.A. has a beta of 0.158, indicating lower volatility than the overall market.
